Medirom Healthcare Technologies Inc

Medirom Healthcare Technologies Inc

MRM · NASDAQ · Consumer Cyclical / Personal Services

0.277USD-0.01 (-2.33%)

Price History

Full chart

Market Stats

Previous Close0.2836
Open0.31
Day Range0.277 – 0.3209
52-Week Range0.60 – 2.85
Volume7.96K
Market Cap5.85M
P/E (TTM)1.95
Forward P/E0.00
EPS0.38
Dividend Yield0.00%
Beta1.06
50-Day Avg0.9274
200-Day Avg1.26

About

MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Company Details

  • SectorConsumer Cyclical
  • IndustryPersonal Services
  • CEOMr. Kouji Eguchi
  • Employees334
  • Headquarters2-3-1 Daiba, Tokyo, Japan, 135 0091, USA
  • Websitehttps://medirom.co.jp

Leadership

  • Mr. Kouji EguchiCEO & Representative Director · b. 1974
  • Mr. Fumitoshi FujiwaraCFO & Director · b. 1967
  • Mr. Akira AokiExecutive Officer & Chief Medical Officer

Financials

Income Statement

Currency: JPY2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.43B3.91B3.34B5.41B6.95B6.83B8.30B4.04M
Growth (%)-+13.84%-14.50%+61.89%+28.54%-1.81%+21.55%-99.95%
Cost of Revenue2.48B2.96B2.91B3.99B5.05B5.26B6.05B137.79K
Gross Profit956.87M950.76M428.95M1.42B1.90B1.57B2.25B3.90M
Gross Margin27.87%24.33%12.84%26.16%27.36%22.98%27.07%96.59%
Operating Expense883.60M916.41M1.18B1.79B1.81B1.96B2.26B3.49M
Operating Income73.27M34.35M-746.09M-379.53M96.97M-391.58M-18.10M414.31K
Operating Margin2.13%0.88%-22.33%-7.02%1.39%-5.73%-0.22%10.25%
EBITDA158.31M125.07M-551.16M-228.07M373.63M310.08M387.50M513.79K
EBITDA Margin4.61%3.20%-16.49%-4.22%5.37%4.54%4.67%12.71%
Net Income66.31M17.34M-539.17M-990.73M148.97M115.05M148.76M374.72K
Net Income Margin1.93%0.44%-16.14%-18.31%2.14%1.68%1.79%9.27%
R&D--13.47M-----
R&D as % of Total Revenue--0.40%-----
Interest Expense15.48M13.59M13.23M11.95M9.80M36.87M49.74M385.05K
Interest Expense % of Total Revenue0.45%0.35%0.40%0.22%0.14%0.54%0.60%9.53%

Balance Sheet

Currency: JPY2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.52B4.76B5.71B5.75B6.75B6.85B8.09B4.16B
Total Liabilities4.64B4.16B5.22B5.96B6.81B6.63B6.90B2.82B
Total Equity-117.56M600.06M491.26M-208.34M-59.38M210.88M933.27M1.33B
Cash211.69M513.62M1.44B370.62M605.45M106.35M329.40M20.14M
Total Debt2.85B2.36B2.56B2.79B3.23B3.65B3.96B2.33B
Net Debt2.64B1.85B1.12B2.42B2.63B3.54B3.63B2.31B

Cash Flow

Currency: JPY2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow141.87M7.87M-366.42M-557.23M-685.70M-631.74M-1.33B
Investing Cash Flow-79.39M-37.93M-139.60M-83.94M580.44M-328.58M361.39M
Financing Cash Flow-74.47M331.99M1.43B-427.95M340.10M461.21M1.19B
Capital Expenditure34.30M7.41M73.56M113.78M120.74M135.84M564.81M
Free Cash Flow107.57M464.00K-439.98M-671.01M-806.44M-767.58M-1.90B
FCF to OCF75.82%5.90%120.07%120.42%117.61%121.50%142.41%

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Nov 7, 2024Apr 29, 2025Oct 21, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.060.06-0.04-0.04-0.51-0.51-0.11-0.12-0.48-0.48-118.56110.27-87.38
Surprise-------------
Timing-------------

Key Statistics & Ratios

Market Cap5.85M
Enterprise Value30.45M
Trailing P/E1.95
Forward P/E0.00
Price / Sales0.00
Price / Book3.76
EPS0.38
Book Value0.1956
Revenue (TTM)8.07B
Gross Profit (TTM)2.02B
EBITDA149.08M
Profit Margin0.50%
Operating Margin-25.84%
Return on Equity53.19%
Return on Assets-1.78%
Shares Outstanding7.90M
Shares Float5.76M
Beta1.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 5.12
  • Strong Buy
    1

Ownership Breakdown

Institutions
2.17%
Insiders
25.67%
Retail / Other
72.16%

Top Institutional Holders

  • Citadel Advisors Llc
    56.10K0.71%
  • UBS Group AG
    26.55K0.34%
  • TWO SIGMA SECURITIES, LLC
    13.98K0.18%
  • HRT FINANCIAL LLC
    11.90K0.15%
  • GAMMA Investing LLC
    3.80K0.05%
  • Rhumbline Advisers
    1.98K0.03%
  • SRS Capital Advisors Inc
    3000.00%

Top Fund Holders

  • Core Guided Moderate Tax-Managed
    160.00%